International Stem Cell (ISCO) Cost of Revenue (2010 - 2026)
International Stem Cell (ISCO) reported Cost of Revenue of $1.22 million for Q2 2026, up 31.3% from $927,000 a year earlier.
Powered by 
Analysis
International Stem Cell (ISCO) Cost of Revenue (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, International Stem Cell's Cost of Revenue came in at $4.26 million, up 9.7% year-over-year; for FY2025, it was $4.03 million, up 7.1% from FY2024.
- Cost of Revenue has a five-year compound annual growth rate of 7.7% (FY2020 to FY2025).
- By year, Cost of Revenue came in at $3.76 million in FY2024 (+18.3%), $3.18 million in FY2023 (-2.7%), $3.27 million in FY2022 (+11.4%) and $2.94 million in FY2021 (+5.5%).
- The Q2 2026 figure ranks as the highest quarterly Cost of Revenue since Q4 2019.
- The high point for year-over-year Cost of Revenue in five years was Q4 2022 (growth of 54.6%); the low point was Q4 2023 (a decline of 24.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 8.10 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 4.09 Bn |
| 10 | International Stem Cell | 1.12 Mn | -2.85 Mn | 1.46 Mn | 1.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.22 Mn |
| Dec 31, 2025 | 1.07 Mn |
| Sep 30, 2025 | 1.05 Mn |
| Jun 30, 2025 | 927,000.00 |
| Mar 31, 2025 | 992,000.00 |
| Dec 31, 2024 | 990,000.00 |
| Sep 30, 2024 | 974,000.00 |
| Jun 30, 2024 | 913,000.00 |
| Mar 31, 2024 | 887,000.00 |
| Dec 31, 2023 | 863,000.00 |
| Sep 30, 2023 | 781,000.00 |
| Jun 30, 2023 | 713,000.00 |
| Mar 31, 2023 | 824,000.00 |
| Dec 31, 2022 | 1.14 Mn |
| Sep 30, 2022 | 690,000.00 |
| Jun 30, 2022 | 718,000.00 |
| Mar 31, 2022 | 725,000.00 |
| Dec 31, 2021 | 735,000.00 |
| Sep 30, 2021 | 814,000.00 |
| Jun 30, 2021 | 770,000.00 |
API Access
International Stem Cell Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=ISCO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "ISCO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=ISCO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();